Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Dose escalation in locally advanced carcinoma of the prostate
Angel I. Blanco
,
Jeff M. Michalski
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Division of Clinical Research
Department of Radiation Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
10
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dose escalation in locally advanced carcinoma of the prostate'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Treatment Planning
100%
Dose Escalation
100%
Advanced Carcinoma
100%
Prostate Carcinoma
100%
Conformal Radiation Therapy
100%
Local Tumor Control
100%
Locally Advanced
100%
Randomized Trial
50%
High Dose
50%
Overall Survival
50%
Prostate Cancer
50%
Computed Tomography
50%
Bladder
50%
Single Institution
50%
Prostate-specific Antigen
50%
Poorly Differentiated Tumor
50%
Quality of Life
50%
Radiation Dose
50%
Three-dimensional Conformal Radiotherapy
50%
Dose-response
50%
Retrospective Analysis
50%
Radiation Therapy Oncology Group
50%
Prospective Clinical Trial
50%
Bowel
50%
Safe Delivery
50%
Advanced Prostate Cancer
50%
Group Setting
50%
High-dose Radiation Therapy
50%
Image-guided
50%
Radiotherapeutics
50%
High-risk Factors
50%
Cooperative Group
50%
Modern Treatment
50%
Biochemical Recurrence-free Survival
50%
Confirmatory Trials
50%
Medicine and Dentistry
Carcinoma
100%
Conformal Radiotherapy
100%
Neoplasm
66%
Treatment Planning
66%
Prostate Cancer
66%
Drug Megadose
66%
Radiation Therapy
66%
Clinical Trial
33%
Overall Survival
33%
Clinical Stage
33%
Prostate Specific Antigen
33%
Bladder
33%
Computer Assisted Tomography
33%
Tumor
33%
Quality of Life
33%
Dose Response
33%
Oncology
33%
Disease Free Survival
33%
Side Effect
33%